The relation between oxidative stress biomarkers and typical parameters found in patients with Huntington´s disease.
Glutathione reductase activity could be a potential biomarker for symptom onset in asymptomatic gene carriers.
Reduced glutathione could be useful in monitoring the progression of neurodegeneration as an expression of caudate atrophy.